Neuroscience research is becoming increasingly more collaborative and interdisciplinary with partnerships between industry and academia and insights from fields beyond neuroscience. In the age of institutional initiatives and multi-investigator collaborations, scientists from around the world shared their perspectives on the effectiveness of large-scale collaborations versus single-lab, hypothesis-driven science.
Fundamental brain research is still mostly done by small teams using highly customized model systems, procedures, and methods. This artisanal science has led to the neuron doctrine, elucidation of the mechanisms underlying the action potential, the receptive field, and other successes. The complexity of the brain demands comprehensive and coordinated efforts. Current obstacles to large-scale collaborations include inappropriate funding models and the parochial sociology of publishing and credit assignment. Large-scale projects make sense when the endpoint is clearly specified. This is most obvious for projects focused on atlases or method development. For example, a detailed inventory and multimodal description of the brain's cell types would be a potent catalyst for all brain research. This kind of atlas requires a large-scale project employing coordination of many types of standardized experiments and related informatics. But large-scale collaborations are also needed for conceptdriven science. After all, most behaviors and the underlying neural computations still remain unexplained in terms of neural circuits because of the distributed, multi-scale nature of the system. These collaborations could take the form of institutional initiatives (e.g., Allen Institute for Brain Science) or self-organized multi-investigator projects. Concept-driven collaborations might further arise naturally with standardization of experiments and data formats (e.g., NWB). If several laboratories working on related problems share data for collective mining, a deeper understanding will emerge.
The Brain and Its Science
Anna C. Nobre
University of Oxford
The brain paradigm has shifted. From the reactive, integrate-and-fire single neuron, we moved to proactive, dynamical networks. Coincidentally, our science paradigm has shifted analogously. Individual scientists are encouraged to leave the singular focus of their self-contained laboratories and join large-scale scientific enterprises in which their own functional expertise joins those of so many other talented colleagues for the greater good. The benefits are many, but the risks and challenges are also non-trivial. Science, like every human endeavor is political and social at its core. Whereas we naturally turn to the mathematical and physical sciences as our field becomes increasingly theoretical and computational, we should also be learning from social sciences, psychology, and philosophy. These will help us understand group decision-making, responsibility, and ethical behavior as we build scientific collaborations and partnerships, and thus do science better. Science evolved in a highly competitive and individualistic basis. The collaborative and open turn is exciting but requires innovation and safeguards. We have no good models for protecting and crediting individual genius, creativity, and achievement within distributed systems. In sharing and collaborating, we must also preserve competition. Large and dominant scientific monopolies would more than undermine any added value of big science. Some of the ongoing funding initiatives seem impervious to the endless examples of ineffectual behemoths in our histories and current societies.
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Deconstructing Neurocircuits

Viviana Gradinaru
Caltech The brain is the most complex, yet least understood, organ in the human body. Recent brainfocused initiatives have done much worldwide to catalyze interdisciplinary approaches to studying the brain. The brain is just one organ, and it would be naive to study it in isolation from other organ systems. Recent studies have uncovered important connections between the brain and body that have major disease implications. The identification of lymphatic vessels in the brain reveals a mechanism for immune-cell exit that may have implications for meningitis and Alzheimer's disease. The intriguing observations that some forms of Parkinson's disease (PD) might originate in the gut and that vagotomies can decrease PD risk emphasize the relevance of a comprehensive functional and anatomical examination of the peripheral nervous system. The NIH SPARC initiative for Stimulating Peripheral Activity to Relieve Conditions is already underway with team efforts that could improve treatments for chronic pain, diabetes, and heart failure. Efforts to understand these interactions will be aided by ever-improving technologies for studying and interfering with intact biological systems. Technologies that can reveal actionable brainbody nodes include cell-type-specific gene delivery or modification, high-resolution largevolume imaging, and high-throughput data analysis. By complementing hypothesis-driven experimentation, these techniques will help neuroscientists gain a deeper understanding of brain function and disease and how these influence and are influenced by other organ systems.
Experimental Alliances
Zoltan Nusser
Institute of Experimental Medicine, Budapest, Hungary Molecular biology, optical imaging and interrogation, molecular neuroanatomy, electrophysiology, and animal behavior have all experienced unprecedented progress over the past decade and, luckily, there is no sign of slowing in the forthcoming years. There is a consensus in the neuroscience community that in-depth analyses of the functional roles of molecules, synapses, or cell types require the combination of the latest developments in most of the above-mentioned techniques. Many of us are facing the question of whether we should implement more and more techniques in our own labs or collaborate with peers who have the complementary technological know-how. Because most funding bodies reward individual grant proposals that contain complex experimental approaches, many PIs follow the former route. A clear advantage of this is that a single PI could plan, prioritize, and oversee progress in each aspect of the project. However, a disadvantage is that because most PIs possess decades-long experience in only one or two technologies, data obtained with the remaining techniques are often of inferior quality. Another related disadvantage is the suboptimal spending of resources; inexperienced use of expensive, cutting-edge technologies often leads to a series of failed experiments. National and international funding bodies should consider increasing the weight of collaborative calls in their portfolios, supporting alliances between a few laboratories (2, a maximum of 3) in which the best experts (often international) join forces to tackle fundamental questions in neuroscience.
Industry-Academia Collaborations
Anirvan Ghosh
Chief Scientific Officer of E-Scape Bio; former Head of Neuroscience Discovery at Roche Not all problems require collaboration, but the impact that collaborations can have in solving complex problems is beyond question. Collaborations between individual scientists, like Hubel and Wiesel, are the stuff of legend. Large-scale collaborations such as the Human Genome Project have been transformative. Individual investigator-led science will continue to be the foundation of scientific progress, but progress in solving complex problems will require collaborations across traditional boundaries. One area that is primed to benefit is disease biology. Disorders like Alzheimer's, schizophrenia, and autism pose huge costs to society, and efforts to develop therapies could benefit tremendously from industry-academia collaborations. An area of collaboration that holds great promise is at the intersection of technology, academic research, and biotech. Companies like Google, Apple, and Facebook have transformed our experience of the world and have developed incredible capabilities in terms of collecting and analyzing large datasets. These approaches could have a major impact on assessing and treating disease but will require mathematicians, computer scientists, engineers, and neuroscientists to work together. It is now relatively easy to collect large amounts of digital data on smartphones or wearable devices, connect it with individual genotype, and ask how genotype affects behavior and function. We can envision how this would allow us to move from treating illnesses to preventing them. This can only happen with effective collaboration between academia and industry. Efforts like the Chan Zuckerberg Initiative, which has the bold goal of managing or curing all disease, could be particularly impactful by supporting collaborative projects.
Pride-of-Lions Approach to Scientific Organization
Richard Tsien NYU My doctoral work was archetypical ''small science,'' a duet with a brilliant young Oxford don, Denis Noble, published in required alphabetical order in The Journal of Physiology. Times have changed: scientific groups are rarely twosomes, and authorship is hardly ever alphabetical. Still, closeness between advisor and student remains key, arguably the best justification for small science. How can we preserve such relationships, yet capitalize on multiple approaches and large-scale collaborations? I like ''medium science,'' performed by multiple labs each doing small science but working in loose federation. It requires heaps of communication-for example, a weekly group meeting where unfinished work is presented to the whole institute. Trainees get extra counsel from their advisor's close colleagues, acting like aunts and uncles in a pride of lions. Camaraderie, self-interest, and frequent visitors help spread new methods. How about ''big science,'' top-down directed projects involving even bigger groups? When should this come into play? Only when absolutely necessary, when a huge goal truly demands a massive effort. Astronomers, physicists, human geneticists, and large pharma do this but have special reasons. For most of neuroscience, medium-sized structure still delivers the best combination of focused training and diversity to spark innovation. If big science is needed, why not incorporate family-like small science and village-like medium science as components? Even large international programs can benefit-human nature generalizes across national cultures and scientific arenas.
